BioAge Labs, Inc (BIOA)
Healthcare
Drug Manufacturers - Specialty & Generic
—
9.00 $
-63.6%
vs. previous close
Closing price · As of: 31. Jul 2026
BioAge Labs, Inc (BIOA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -82 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2013 | 2014 | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -28 | -22 | -32 | -38 | -30 | -36 | -37 | -52 | -82 | |
| 1.7 | 1.4 | 4.2 | 9.2 | 9.3 | 0.1 | 0.2 | 0.2 | 0.2 | |
| 6.7 | 6.9 | 4.8 | 3.6 | 5.2 | 2.5 | 3.0 | 7.0 | 12 | |
| 76 | -43 | -53 | 5.0 | 18 | 0.8 | 6.7 | 11 | -12 | |
| 13 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.4 | 0.7 | |
| – | – | – | – | – | -0.1 | -0.3 | -0.4 | -95 | |
| -84 | -51 | -7.0 | -16 | -4.6 | – | – | – | – | |
| – | – | – | – | – | 2.5 | 35 | -6.0 | -6.0 | |
| 100 | 79 | 55 | 47 | 19 | 2.5 | 35 | 381 | 11 | |
| 59 | -33 | -44 | 9.2 | -12 | -34 | -2.7 | 329 | -165 | |
| -40 | -22 | -32 | -38 | -30 | -36 | -38 | -52 | -82 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.